Sergii A. Lyalkin

33/43 Lomonosova Str
03022, Ukraine

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Cancer-Associated Thrombosis in Breast Cancer: Risk Factors and Personalized Management.

Cancer-Associated Thrombosis in Breast Cancer: Risk Factors and Personalized Management.

Journal: Journal of clinical medicine

Published: December 29, 2025

Visualisation of magnetic field-induced nanoparticle clusters and mechanical property changes in a breast phantom for inductive moderate hyperthermia.

Visualisation of magnetic field-induced nanoparticle clusters and mechanical property changes in a breast phantom for inductive moderate hyperthermia.

Journal: Biomedical engineering online

Published: July 14, 2025

CHOLANGIOCARCINOMA IN TWIN PREGNANCY: A CASE REPORT.

CHOLANGIOCARCINOMA IN TWIN PREGNANCY: A CASE REPORT.

Journal: Experimental oncology

Published: July 11, 2025

Combination Treatment with Free Doxorubicin and Inductive Moderate Hyperthermia for Sarcoma Saos-2 Cells.

Combination Treatment with Free Doxorubicin and Inductive Moderate Hyperthermia for Sarcoma Saos-2 Cells.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: April 10, 2025

A COMPARATIVE STUDY OF CARDIOVASCULAR TOXICITY OF EPIRUBICIN AND DOXORUBICIN IN PATIENTS WITH BREAST CANCER.

A COMPARATIVE STUDY OF CARDIOVASCULAR TOXICITY OF EPIRUBICIN AND DOXORUBICIN IN PATIENTS WITH BREAST CANCER.

Journal: Problemy radiatsiinoi medytsyny ta radiobiolohii

Published: November 06, 2024

Characterization and antitumor effect of doxorubicin-loaded Fe3O4-Au nanocomposite synthesized by electron beam evaporation for magnetic nanotheranostics.

Characterization and antitumor effect of doxorubicin-loaded Fe3O4-Au nanocomposite synthesized by electron beam evaporation for magnetic nanotheranostics.

Journal: RSC advances

Published: March 07, 2024

EXPRESSION PROFILE OF miR-145, -182, -21, -27a, -29b, and -34a IN BREAST CANCER PATIENTS OF YOUNG AGE.

EXPRESSION PROFILE OF miR-145, -182, -21, -27a, -29b, and -34a IN BREAST CANCER PATIENTS OF YOUNG AGE.

Journal: Experimental oncology

Published: February 01, 2024

RISK SCORE MODEL FOR PREDICTING CARDIOTOXICITY IN BREAST CANCER: DIAGNOSTIC VALUE OF HIGH-SENSITIVITY CARDIAC TROPONIN T.

RISK SCORE MODEL FOR PREDICTING CARDIOTOXICITY IN BREAST CANCER: DIAGNOSTIC VALUE OF HIGH-SENSITIVITY CARDIAC TROPONIN T.

Journal: Problemy radiatsiinoi medytsyny ta radiobiolohii

Published: September 19, 2023

PATTERN OF MMP2 AND MMP9 EXPRESSION DEPENDS ON BREAST CANCER PATIENTS' AGE.

PATTERN OF MMP2 AND MMP9 EXPRESSION DEPENDS ON BREAST CANCER PATIENTS' AGE.

Journal: Experimental oncology

Published: June 25, 2023

PROGNOSTIC ROLE OF RESIDUAL TUMOR FEATURES IN HER2-NEGATIVE BREAST CANCER.

PROGNOSTIC ROLE OF RESIDUAL TUMOR FEATURES IN HER2-NEGATIVE BREAST CANCER.

Journal: Experimental oncology

Published: November 03, 2022

CARDIOTOXICITY IN BREAST CANCER PATIENTS: RELATIONSHIP OF HS-TROPONIN T CHANGES AND HEART FUNCTION IN CANCER TREATMENT.

CARDIOTOXICITY IN BREAST CANCER PATIENTS: RELATIONSHIP OF HS-TROPONIN T CHANGES AND HEART FUNCTION IN CANCER TREATMENT.

Journal: Problemy radiatsiinoi medytsyny ta radiobiolohii

Published: April 18, 2022

CARDIOTOXICITY RISK PREDICTION IN BREAST CANCER PATIENTS.

CARDIOTOXICITY RISK PREDICTION IN BREAST CANCER PATIENTS.

Journal: Problemy radiatsiinoi medytsyny ta radiobiolohii

Published: August 03, 2021

Showing 1-12 of 15

Last Updated: 09/26/2026